臨床試驗

Dapagliflozin and Right Heart Recovery After ASD Device Closure

NCT：NCT07823972 · NOT_YET_RECRUITING

NCT IDNCT07823972

狀態NOT_YET_RECRUITING

開始日期2026-11-01

完成時間2029-01-30

SponsorAssiut University (OTHER)

First posted2026-09-17

Last updated2026-09-17

簡要摘要

The aim of this study is to evaluate the clinical and echocardiographic influence of dapagliflozin on right ventricular reverse remodeling in adult patients following successful transcatheter Atrial Septal Defect (ASD) device closure.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。